SEOUL, South Korean pharmaceutical company Legochem Biosciences Inc. said Monday that it will sell new shares to raise 469.8 billion won (US$355.9 million). The company said in a regulatory filing that it will issue some 7.96 million common shares at a price of 59,000 won per share to third-party investor Pan Orion Corp. The proceeds from the rights offering will be used primarily to finance its operations, said Legochem Biosciences registered on the country's secondary KOSDAQ market. Source: Yonhap News Agency